134 related articles for article (PubMed ID: 38037182)
21. BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors.
Prabowo AS; Iyer AM; Veersema TJ; Anink JJ; Schouten-van Meeteren AY; Spliet WG; van Rijen PC; Ferrier CH; Capper D; Thom M; Aronica E
Brain Pathol; 2014 Jan; 24(1):52-66. PubMed ID: 23941441
[TBL] [Abstract][Full Text] [Related]
22. MR Imaging of Pediatric Low-Grade Gliomas: Pretherapeutic Differentiation of
Trasolini A; Erker C; Cheng S; Crowell C; McFadden K; Moineddin R; Sargent MA; Mata-Mbemba D
AJNR Am J Neuroradiol; 2022 Aug; 43(8):1196-1201. PubMed ID: 35863783
[TBL] [Abstract][Full Text] [Related]
23. BRAF Inhibition in
Kaley T; Touat M; Subbiah V; Hollebecque A; Rodon J; Lockhart AC; Keedy V; Bielle F; Hofheinz RD; Joly F; Blay JY; Chau I; Puzanov I; Raje NS; Wolf J; DeAngelis LM; Makrutzki M; Riehl T; Pitcher B; Baselga J; Hyman DM
J Clin Oncol; 2018 Dec; 36(35):3477-3484. PubMed ID: 30351999
[TBL] [Abstract][Full Text] [Related]
24. Clinico-pathological and molecular characterization of diffuse midline gliomas: is there a prognostic significance?
Manjunath N; Jha P; Singh J; Raheja A; Kaur K; Suri A; Garg A; Sharma MC; Sarkar C; Mohan M; Mani K; Suri V
Neurol Sci; 2021 Mar; 42(3):925-934. PubMed ID: 32666407
[TBL] [Abstract][Full Text] [Related]
25. [BRAF V600E mutation and clinicopathologic characteristics in 250 cases of brain tumors associated with epilepsy].
Qi XL; Yao K; Duan ZJ; Bian Y; Ma Z; Piao YS; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):664-670. PubMed ID: 30220118
[No Abstract] [Full Text] [Related]
26. BRAF
Wang W; Wang M; Jiang H; Wang T; Da R
BMC Neurol; 2021 May; 21(1):195. PubMed ID: 33980169
[TBL] [Abstract][Full Text] [Related]
27. BRAF V600E mutation and 9p21: CDKN2A/B and MTAP co-deletions - Markers in the clinical stratification of pediatric gliomas.
Frazão L; do Carmo Martins M; Nunes VM; Pimentel J; Faria C; Miguéns J; Sagarribay A; Matos M; Salgado D; Nunes S; Mafra M; Roque L
BMC Cancer; 2018 Dec; 18(1):1259. PubMed ID: 30558563
[TBL] [Abstract][Full Text] [Related]
28. Molecular Alterations in Pediatric Low-Grade Gliomas That Led to Death.
Ahrendsen JT; Sinai C; Meredith DM; Malinowski SW; Cooney TM; Bandopadhayay P; Ligon KL; Alexandrescu S
J Neuropathol Exp Neurol; 2021 Nov; 80(11):1052–1059. PubMed ID: 34580728
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of H3 K27M-mutant gliomas in adults.
Meyronet D; Esteban-Mader M; Bonnet C; Joly MO; Uro-Coste E; Amiel-Benouaich A; Forest F; Rousselot-Denis C; Burel-Vandenbos F; Bourg V; Guyotat J; Fenouil T; Jouvet A; Honnorat J; Ducray F
Neuro Oncol; 2017 Aug; 19(8):1127-1134. PubMed ID: 28201752
[TBL] [Abstract][Full Text] [Related]
30. T2-FLAIR Mismatch Sign in Pediatric Low-Grade Glioma.
Wagner MW; Nobre L; Namdar K; Khalvati F; Tabori U; Hawkins C; Ertl-Wagner BB
AJNR Am J Neuroradiol; 2023 Jul; 44(7):841-845. PubMed ID: 37348970
[TBL] [Abstract][Full Text] [Related]
31. KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.
Becker AP; Scapulatempo-Neto C; Carloni AC; Paulino A; Sheren J; Aisner DL; Musselwhite E; Clara C; Machado HR; Oliveira RS; Neder L; Varella-Garcia M; Reis RM
J Neuropathol Exp Neurol; 2015 Jul; 74(7):743-54. PubMed ID: 26083571
[TBL] [Abstract][Full Text] [Related]
32. Four methods to analyze H3K27M mutation in diffuse midline gliomas.
Zhao H; Fang X; Xue B
Pathol Res Pract; 2020 Sep; 216(9):153065. PubMed ID: 32825938
[TBL] [Abstract][Full Text] [Related]
33. Adult diffuse midline gliomas: Clinical, radiological, and genetic characteristics.
Dono A; Takayasu T; Ballester LY; Esquenazi Y
J Clin Neurosci; 2020 Dec; 82(Pt A):1-8. PubMed ID: 33317715
[TBL] [Abstract][Full Text] [Related]
34. BRAF Mutation is Associated with an Improved Survival in Glioma-a Systematic Review and Meta-analysis.
Vuong HG; Altibi AMA; Duong UNP; Ngo HTT; Pham TQ; Fung KM; Hassell L
Mol Neurobiol; 2018 May; 55(5):3718-3724. PubMed ID: 28534272
[TBL] [Abstract][Full Text] [Related]
35. Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas.
Lazow MA; Hoffman L; Schafer A; Osorio DS; Boué DR; Rush S; Wright E; Lane A; DeWire-Schottmiller MD; Smolarek T; Sipple J; Taggert H; Reuss J; Salloum R; Hummel TR; de Blank P; Pillay-Smiley N; Sutton ME; Asher A; Stevenson CB; Drissi R; Finlay JL; Fouladi M; Fuller C
Acta Neuropathol Commun; 2020 Nov; 8(1):182. PubMed ID: 33153497
[TBL] [Abstract][Full Text] [Related]
36. Actionable FGFR1 and BRAF mutations in adult circumscribed gliomas.
Trisolini E; Wardighi DE; Giry M; Bernardi P; Boldorini RL; Mokhtari K; Sanson M
J Neurooncol; 2019 Nov; 145(2):241-245. PubMed ID: 31673897
[TBL] [Abstract][Full Text] [Related]
37. Morphological and molecular features of astroblastoma, including BRAFV600E mutations, suggest an ontological relationship to other cortical-based gliomas of children and young adults.
Lehman NL; Hattab EM; Mobley BC; Usubalieva A; Schniederjan MJ; McLendon RE; Paulus W; Rushing EJ; Georgescu MM; Couce M; Dulai MS; Cohen ML; Pierson CR; Raisanen JM; Martin SE; Lehman TD; Lipp ES; Bonnin JM; Al-Abbadi MA; Kenworthy K; Zhao K; Mohamed N; Zhang G; Zhao W
Neuro Oncol; 2017 Jan; 19(1):31-42. PubMed ID: 27416954
[TBL] [Abstract][Full Text] [Related]
38. Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors.
Rivera B; Gayden T; Carrot-Zhang J; Nadaf J; Boshari T; Faury D; Zeinieh M; Blanc R; Burk DL; Fahiminiya S; Bareke E; Schüller U; Monoranu CM; Sträter R; Kerl K; Niederstadt T; Kurlemann G; Ellezam B; Michalak Z; Thom M; Lockhart PJ; Leventer RJ; Ohm M; MacGregor D; Jones D; Karamchandani J; Greenwood CM; Berghuis AM; Bens S; Siebert R; Zakrzewska M; Liberski PP; Zakrzewski K; Sisodiya SM; Paulus W; Albrecht S; Hasselblatt M; Jabado N; Foulkes WD; Majewski J
Acta Neuropathol; 2016 Jun; 131(6):847-63. PubMed ID: 26920151
[TBL] [Abstract][Full Text] [Related]
39. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma.
Schindler G; Capper D; Meyer J; Janzarik W; Omran H; Herold-Mende C; Schmieder K; Wesseling P; Mawrin C; Hasselblatt M; Louis DN; Korshunov A; Pfister S; Hartmann C; Paulus W; Reifenberger G; von Deimling A
Acta Neuropathol; 2011 Mar; 121(3):397-405. PubMed ID: 21274720
[TBL] [Abstract][Full Text] [Related]
40. Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs).
Kakkar A; Majumdar A; Kumar A; Tripathi M; Pathak P; Sharma MC; Suri V; Tandon V; Chandra SP; Sarkar C
Epilepsy Res; 2016 Nov; 127():141-151. PubMed ID: 27599148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]